HKG Equity Snapshot
2509 Weekly Equity Report
Qyuns Therapeutics Co., Ltd.
What the company does
Qyuns Therapeutics Co., Ltd., a clinical-stage biotech company, engages in the research and development of biologic therapies for autoimmune and allergic diseases in China. Its lead product candidates include QX002N, an interleukin (IL)-17A inhibitor, which completed Phase III clinical trial for the treatment of ankylosing spondylitis; and QX005N, a monoclonal antibody (mAb) blocking IL-4Ra that is in Phase III clinical trial for treating prurigo nodularis. The company also develops QX001S, which is an IL-12/L-23p40 inhibitor for psoriasis under the SAILEXIN brand. In addition, the company develops QX008N, a humanized IgG1 mAb targeting thymic stromal lymphopoietin …
What the weekly tape is saying
2509 closed the latest completed week at 16.01 HKD. The 4-week return is -6.7% and the 12-week return is -10.2%. Trend Signal is inactive, Market Dynamics is -0.97. Setup signature: Risk-first tape with a 17/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 19.05 HKD
- Vs Trend Line
- -15.9%
- Fair Value
- 18.29 HKD
- Vs Fair Value
- -12.5%
- 52W High
- 36.50 HKD
- 52W Low
- 14.02 HKD
- Drawdown
- -56.1%
- Range Position
- 8.9%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 24
- 52W Active Breadth
- 46.2%
- Sector Scope
- HK Healthcare
- Sector Rank
- 29 of 257
- Sector Percentile
- 89.1%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
HK Healthcare
- Tracked Peers
- 100
- 4W Rank
- - of 100
- Avg 1W
- -1.3%
- Avg 4W
- -12.8%
- Trend Breadth
- 6.0%
- Positive MD
- 10.0%
HK Biotechnology
- Tracked Peers
- 76
- 4W Rank
- 13 of 76
- Avg 1W
- -1.6%
- Avg 4W
- -17.5%
- Trend Breadth
- 3.9%
- Positive RS
- 5.3%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -0.97
- 4W MD Change
- -22.5%
- Relative Strength
- -19.48
- 4W RS Change
- -12.2%
- Expectation
- Undecided
- Probability
- 51.24%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 749.2K
- 13W Average
- 1.4M
- 52W Average
- 2.2M
- Vs 13W
- 0.5x
- Vs 52W
- 0.3x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 6.5%
- 52W Volatility
- 9.1%
- Upside Weeks
- 25
- Downside Weeks
- 27
- Downside Breadth
- 51.9%
- Avg Gain / Loss
- 8.0% / -6.8%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- HKG
- Country
- HK
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- HKD
- Market Cap
- 3.7B
Opportunity signals
- No strong opportunity cluster is confirmed yet; monitor trend and Market Dynamics.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 16.01 HKD | 5.1% | 19.05 HKD | 18.29 HKD | -0.97 | -19.48 | 749.2K | Off |
| 5 Jun 2026 | 15.23 HKD | -9.7% | 19.22 HKD | 18.31 HKD | -0.87 | -24.25 | 1.7M | Off |
| 29 May 2026 | 16.86 HKD | 8.6% | 19.35 HKD | 18.34 HKD | -0.91 | -16.90 | 884.6K | Off |
| 22 May 2026 | 15.53 HKD | -9.5% | 19.51 HKD | 18.35 HKD | -0.96 | -24.40 | 701.8K | Off |
| 15 May 2026 | 17.16 HKD | 2.8% | 19.79 HKD | 18.37 HKD | -0.79 | -17.37 | 1.6M | Off |
| 8 May 2026 | 16.70 HKD | -2.9% | 20.17 HKD | 18.38 HKD | -0.52 | -20.52 | 1.6M | Off |
| 1 May 2026 | 17.20 HKD | -4.5% | 20.59 HKD | 18.40 HKD | -0.22 | -15.89 | 815.4K | Off |
| 24 Apr 2026 | 18.01 HKD | -12.1% | 21.15 HKD | 18.41 HKD | 0.20 | -12.25 | 1.7M | Off |
| 17 Apr 2026 | 20.48 HKD | -0.2% | 21.53 HKD | 18.41 HKD | 0.36 | -0.44 | 3.4M | Off |
| 10 Apr 2026 | 20.52 HKD | 3.2% | 21.83 HKD | 18.40 HKD | 0.07 | 1.68 | 1.4M | Off |
| 3 Apr 2026 | 19.88 HKD | 2.6% | 22.20 HKD | 18.38 HKD | -0.15 | 2.56 | 2.4M | Off |
| 27 Mar 2026 | 19.38 HKD | 8.8% | 22.38 HKD | 18.36 HKD | -0.49 | 1.65 | 1.1M | Off |
| 20 Mar 2026 | 17.82 HKD | 0.1% | 22.53 HKD | 18.35 HKD | -0.59 | -6.81 | 334.1K | Off |
| 13 Mar 2026 | 17.81 HKD | 2.6% | 22.85 HKD | 18.36 HKD | -0.52 | -6.78 | 823.4K | Off |